ID   PERT_HUMAN              Reviewed;         933 AA.
AC   P07202; P09934; P09935; Q8IUL0; Q8NF94; Q8NF95; Q8NF96; Q8NF97; Q8TCI9;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 4.
DT   28-JUN-2023, entry version 255.
DE   RecName: Full=Thyroid peroxidase {ECO:0000305};
DE            Short=TPO;
DE            EC=1.11.1.8 {ECO:0000250|UniProtKB:P09933};
DE   Flags: Precursor;
GN   Name=TPO {ECO:0000312|HGNC:HGNC:12015};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANTS PRO-725 AND
RP   ALA-847.
RX   PubMed=3475693; DOI=10.1073/pnas.84.16.5555;
RA   Kimura S., Kotani T., McBride O.W., Umeki K., Hirai K., Nakayama T.,
RA   Ohtaki S.;
RT   "Human thyroid peroxidase: complete cDNA and protein sequence, chromosome
RT   mapping, and identification of two alternately spliced mRNAs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:5555-5559(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS PRO-725 AND ALA-847.
RC   TISSUE=Thyroid;
RX   PubMed=3453124; DOI=10.1093/nar/15.16.6735;
RA   Libert F., Ruel J., Ludgate M., Swillens S., Alexander N., Vassart G.,
RA   Dinsart C.;
RT   "Complete nucleotide sequence of the human thyroperoxidase-microsomal
RT   antigen cDNA.";
RL   Nucleic Acids Res. 15:6735-6735(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=2548579; DOI=10.1021/bi00436a054;
RA   Kimura S., Hong Y.S., Kotani T., Ohtaki S., Kikkawa F.;
RT   "Structure of the human thyroid peroxidase gene: comparison and
RT   relationship to the human myeloperoxidase gene.";
RL   Biochemistry 28:4481-4489(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Thyroid;
RX   PubMed=2308857; DOI=10.1093/nar/18.3.670;
RA   Barnett P.S., Banga J.P., Watkins J., Huang G.C., Gluckman D.R.B.,
RA   Page M.J., McGregor A.M.;
RT   "Nucleotide sequence of the alternatively spliced human thyroid peroxidase
RT   cDNA, TPO-2.";
RL   Nucleic Acids Res. 18:670-670(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-257.
RC   TISSUE=Thyroid;
RA   Rapoport B.;
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND VARIANTS SER-257; PRO-725 AND
RP   ALA-847.
RC   TISSUE=Thyroid;
RA   Hennen G.P., Igout A., Melen L.B.;
RT   "Homo sapiens thyroid peroxidase (TPO) variant mRNA, alternatively spliced
RT   sequence.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4; 5; 6; 2-3 AND 2-4), AND
RP   VARIANTS PRO-725 AND ALA-847.
RC   TISSUE=Thyroid;
RX   PubMed=12454013; DOI=10.1074/jbc.m209513200;
RA   Ferrand M., Le Fourn V., Franc J.-L.;
RT   "Increasing diversity of human thyroperoxidase generated by alternative
RT   splicing. Characterization by molecular cloning of new transcripts with
RT   single- and multispliced mRNAs.";
RL   J. Biol. Chem. 278:3793-3800(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 217-496.
RX   PubMed=3654979; DOI=10.1172/jci113181;
RA   Seto P., Hirayu H., Magnusson R.P., Gestautas J., Portmann L.,
RA   Degroot L.J., Rapoport B.;
RT   "Isolation of a complementary DNA clone for thyroid microsomal antigen.
RT   Homology with the gene for thyroid peroxidase.";
RL   J. Clin. Invest. 80:1205-1208(1987).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 670-933 (ISOFORM 3), AND ALTERNATIVE SPLICING
RP   IN GRAVES' DISEASE.
RC   TISSUE=Thyroid;
RX   PubMed=2383265; DOI=10.1016/0006-291x(90)92152-p;
RA   Zanelli E., Henry M., Charvet B., Malthiery Y.;
RT   "Evidence for an alternate splicing in the thyroperoxidase messenger from
RT   patients with Graves' disease.";
RL   Biochem. Biophys. Res. Commun. 170:735-741(1990).
RN   [10]
RP   INTERACTION WITH DUOX1; DUOX2 AND CYBA.
RX   PubMed=15561711; DOI=10.1074/jbc.m407709200;
RA   Wang D., De Deken X., Milenkovic M., Song Y., Pirson I., Dumont J.E.,
RA   Miot F.;
RT   "Identification of a novel partner of duox: EFP1, a thioredoxin-related
RT   protein.";
RL   J. Biol. Chem. 280:3096-3103(2005).
RN   [11]
RP   VARIANTS TDH2A ASP-453; SER-590 AND LYS-799, AND VARIANTS SER-257; SER-373;
RP   THR-398 AND PRO-725.
RX   PubMed=7550241; DOI=10.1002/humu.1380060104;
RA   Bikker H., Vulsma T., Baas F., de Vijlder J.J.M.;
RT   "Identification of five novel inactivating mutations in the human thyroid
RT   peroxidase gene by denaturing gradient gel electrophoresis.";
RL   Hum. Mutat. 6:9-16(1995).
RN   [12]
RP   VARIANT TDH2A PHE-447.
RX   PubMed=9024270; DOI=10.1210/jcem.82.2.3729;
RA   Bikker H., Baas F., De Vijlder J.J.M.;
RT   "Molecular analysis of mutated thyroid peroxidase detected in patients with
RT   total iodide organification defects.";
RL   J. Clin. Endocrinol. Metab. 82:649-653(1997).
RN   [13]
RP   VARIANT TDH2A GLU-660.
RX   PubMed=10468986; DOI=10.1046/j.1365-2265.1999.00746.x;
RA   Santos C.L.S., Bikker H., Rego K.G.M., Nascimento A.C., Tambascia M.,
RA   De Vijlder J.J.M., Medeiros-Neto G.;
RT   "A novel mutation in the TPO gene in goitrous hypothyroid patients with
RT   iodide organification defect.";
RL   Clin. Endocrinol. (Oxf.) 51:165-172(1999).
RN   [14]
RP   VARIANTS TDH2A GLN-648 AND LYS-799.
RX   PubMed=10084596; DOI=10.1210/jcem.84.3.5541;
RA   Pannain S., Weiss R.E., Jackson C.E., Dian D., Beck J.C., Sheffield V.C.,
RA   Cox N., Refetoff S.;
RT   "Two different mutations in the thyroid peroxidase gene of a large inbred
RT   Amish kindred: power and limits of homozygosity mapping.";
RL   J. Clin. Endocrinol. Metab. 84:1061-1071(1999).
RN   [15]
RP   VARIANT TDH2A ASN-240, AND CHARACTERIZATION OF VARIANT TDH2A ASN-240.
RX   PubMed=9924196; DOI=10.1677/joe.0.1600267;
RA   Kotani T., Umeki K., Yamamoto I., Maesaka H., Tachibana K., Ohtaki S.;
RT   "A novel mutation in the human thyroid peroxidase gene resulting in a total
RT   iodide organification defect.";
RL   J. Endocrinol. 160:267-273(1999).
RN   [16]
RP   VARIANTS TDH2A THR-326; PHE-447; ASP-453; CYS-527; TRP-693 AND LYS-799.
RX   PubMed=11061528; DOI=10.1210/jcem.85.10.6878;
RA   Bakker B., Bikker H., Vulsma T., de Randamie J.S.E., Wiedijk B.M.,
RA   De Vijlder J.J.M.;
RT   "Two decades of screening for congenital hypothyroidism in The Netherlands:
RT   TPO gene mutations in total iodide organification defects (an update).";
RL   J. Clin. Endocrinol. Metab. 85:3708-3712(2000).
RN   [17]
RP   VARIANTS TDH2A PRO-458 AND HIS-491.
RX   PubMed=11415848; DOI=10.1530/eje.0.1450019;
RA   Ambrugger P., Stoeva I., Biebermann H., Torresani T., Leitner C.,
RA   Grueters A.;
RT   "Novel mutations of the thyroid peroxidase gene in patients with permanent
RT   congenital hypothyroidism.";
RL   Eur. J. Endocrinol. 145:19-24(2001).
RN   [18]
RP   VARIANTS TDH2A TRP-665 AND ARG-771, AND CHARACTERIZATION OF VARIANTS TDH2A
RP   TRP-665 AND ARG-771.
RX   PubMed=11916616; DOI=10.1530/eje.0.1460491;
RA   Umeki K., Kotani T., Kawano J., Suganuma T., Yamamoto I., Aratake Y.,
RA   Furujo M., Ichiba Y.;
RT   "Two novel missense mutations in the thyroid peroxidase gene, R665W and
RT   G771R, result in a localization defect and cause congenital
RT   hypothyroidism.";
RL   Eur. J. Endocrinol. 146:491-498(2002).
RN   [19]
RP   VARIANT TDH2A PRO-53.
RX   PubMed=12213873; DOI=10.1210/jc.2002-020153;
RA   Niu D.-M., Hwang B., Chu Y.-K., Liao C.-J., Wang P.-L., Lin C.-Y.;
RT   "High prevalence of a novel mutation (2268 insT) of the thyroid peroxidase
RT   gene in Taiwanese patients with total iodide organification defect, and
RT   evidence for a founder effect.";
RL   J. Clin. Endocrinol. Metab. 87:4208-4212(2002).
RN   [20]
RP   VARIANTS TDH2A SER-493 AND TYR-796.
RX   PubMed=11874711; DOI=10.1677/joe.0.1720627;
RA   Wu J.-Y., Shu S.-G., Yang C.-F., Lee C.-C., Tsai F.-J.;
RT   "Mutation analysis of thyroid peroxidase gene in Chinese patients with
RT   total iodide organification defect: identification of five novel
RT   mutations.";
RL   J. Endocrinol. 172:627-635(2002).
RN   [21]
RP   VARIANT TDH2A ILE-839.
RX   PubMed=12490071; DOI=10.1089/105072502320908277;
RA   Calaciura F., Miscio G., Coco A., Leonardi D., Cisternino C., Regalbuto C.,
RA   Bozzali M., Maiorana R., Ranieri A., Carta A., Buscema M., Trischitta V.,
RA   Sava L., Tassi V.;
RT   "Genetics of specific phenotypes of congenital hypothyroidism: a
RT   population-based approach.";
RL   Thyroid 12:945-951(2002).
RN   [22]
RP   VARIANTS TDH2A CYS-533 AND ASP-574-575-LEU DEL, AND CHARACTERIZATION OF
RP   VARIANTS TDH2A CYS-533 AND ASP-574-575-LEU DEL.
RX   PubMed=12864797; DOI=10.1046/j.1365-2265.2003.01823.x;
RA   Kotani T., Umeki K., Kawano J., Suganuma T., Hishinuma A., Ieiri T.,
RA   Harada S.;
RT   "Partial iodide organification defect caused by a novel mutation of the
RT   thyroid peroxidase gene in three siblings.";
RL   Clin. Endocrinol. (Oxf.) 59:198-206(2003).
RN   [23]
RP   VARIANTS TDH2A THR-307; MET-433; LEU-499 AND ARG-808.
RX   PubMed=12938097; DOI=10.1002/humu.9175;
RA   Rivolta C.M., Esperante S.A., Gruneiro-Papendieck L., Chiesa A., Moya C.M.,
RA   Domene S., Varela V., Targovnik H.M.;
RT   "Five novel inactivating mutations in the thyroid peroxidase gene
RT   responsible for congenital goiter and iodide organification defect.";
RL   Hum. Mutat. 22:259-259(2003).
RN   [24]
RP   VARIANT TDH2A TRP-693.
RX   PubMed=12843174; DOI=10.1210/jc.2002-021377;
RA   Fugazzola L., Cerutti N., Mannavola D., Vannucchi G., Fallini C.,
RA   Persani L., Beck-Peccoz P.;
RT   "Monoallelic expression of mutant thyroid peroxidase allele causing total
RT   iodide organification defect.";
RL   J. Clin. Endocrinol. Metab. 88:3264-3271(2003).
RN   [25]
RP   VARIANT TDH2A LYS-378.
RX   PubMed=16284446; DOI=10.1507/endocrj.52.643;
RA   Tajima T., Tsubaki J., Fujieda K.;
RT   "Two novel mutations in the thyroid peroxidase gene with goitrous
RT   hypothyroidism.";
RL   Endocr. J. 52:643-645(2005).
RN   [26]
RP   VARIANT TDH2A ASP-453.
RX   PubMed=16684826; DOI=10.1210/jc.2006-0142;
RA   Pfarr N., Borck G., Turk A., Napiontek U., Keilmann A., Mueller-Forell W.,
RA   Kopp P., Pohlenz J.;
RT   "Goitrous congenital hypothyroidism and hearing impairment associated with
RT   mutations in the TPO and SLC26A4/PDS genes.";
RL   J. Clin. Endocrinol. Metab. 91:2678-2681(2006).
RN   [27]
RP   VARIANTS TDH2A HIS-412 AND 596-GLU--LEU-933 DEL.
RX   PubMed=27305979; DOI=10.1038/jhg.2016.62;
RA   Mittal K., Rafiq M.A., Rafiullah R., Harripaul R., Ali H., Ayaz M.,
RA   Aslam M., Naeem F., Amin-Ud-Din M., Waqas A., So J., Rappold G.A.,
RA   Vincent J.B., Ayub M.;
RT   "Mutations in the genes for thyroglobulin and thyroid peroxidase cause
RT   thyroid dyshormonogenesis and autosomal-recessive intellectual
RT   disability.";
RL   J. Hum. Genet. 61:867-872(2016).
CC   -!- FUNCTION: Iodination and coupling of the hormonogenic tyrosines in
CC       thyroglobulin to yield the thyroid hormones T(3) and T(4).
CC       {ECO:0000250|UniProtKB:P09933}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 H(+) + H2O2 + 2 iodide = diiodine + 2 H2O;
CC         Xref=Rhea:RHEA:23336, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16240, ChEBI:CHEBI:16382, ChEBI:CHEBI:17606; EC=1.11.1.8;
CC         Evidence={ECO:0000250|UniProtKB:P09933};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thyroglobulin]-L-tyrosine + H(+) + H2O2 + iodide =
CC         [thyroglobulin]-3-iodo-L-tyrosine + 2 H2O; Xref=Rhea:RHEA:48956,
CC         Rhea:RHEA-COMP:12274, Rhea:RHEA-COMP:12275, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16240, ChEBI:CHEBI:16382,
CC         ChEBI:CHEBI:46858, ChEBI:CHEBI:90870; EC=1.11.1.8;
CC         Evidence={ECO:0000250|UniProtKB:P09933};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thyroglobulin]-3-iodo-L-tyrosine + H(+) + H2O2 + iodide =
CC         [thyroglobulin]-3,5-diiodo-L-tyrosine + 2 H2O; Xref=Rhea:RHEA:48960,
CC         Rhea:RHEA-COMP:12275, Rhea:RHEA-COMP:12276, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16240, ChEBI:CHEBI:16382,
CC         ChEBI:CHEBI:90870, ChEBI:CHEBI:90871; EC=1.11.1.8;
CC         Evidence={ECO:0000250|UniProtKB:P09933};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 [thyroglobulin]-3,5-diiodo-L-tyrosine + H2O2 =
CC         [thyroglobulin]-dehydroalanine + [thyroglobulin]-L-thyroxine + 2 H2O;
CC         Xref=Rhea:RHEA:48964, Rhea:RHEA-COMP:12276, Rhea:RHEA-COMP:12277,
CC         Rhea:RHEA-COMP:12278, ChEBI:CHEBI:15377, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:90871, ChEBI:CHEBI:90872, ChEBI:CHEBI:90873; EC=1.11.1.8;
CC         Evidence={ECO:0000250|UniProtKB:P09933};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thyroglobulin]-3,5-diiodo-L-tyrosine + [thyroglobulin]-3-
CC         iodo-L-tyrosine + H2O2 = [thyroglobulin]-3,3',5-triiodo-L-thyronine +
CC         [thyroglobulin]-dehydroalanine + 2 H2O; Xref=Rhea:RHEA:48968,
CC         Rhea:RHEA-COMP:12275, Rhea:RHEA-COMP:12276, Rhea:RHEA-COMP:12278,
CC         Rhea:RHEA-COMP:12279, ChEBI:CHEBI:15377, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:90870, ChEBI:CHEBI:90871, ChEBI:CHEBI:90873,
CC         ChEBI:CHEBI:90874; EC=1.11.1.8;
CC         Evidence={ECO:0000250|UniProtKB:P09933};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00298};
CC       Note=Binds 1 Ca(2+) ion per heterodimer. {ECO:0000255|PROSITE-
CC       ProRule:PRU00298};
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00298};
CC       Note=Binds 1 heme b (iron(II)-protoporphyrin IX) group covalently per
CC       heterodimer. {ECO:0000255|PROSITE-ProRule:PRU00298};
CC   -!- PATHWAY: Hormone biosynthesis; thyroid hormone biosynthesis.
CC   -!- SUBUNIT: Interacts with DUOX1, DUOX2 and CYBA.
CC       {ECO:0000269|PubMed:15561711}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cell surface.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=TPO1;
CC         IsoId=P07202-1; Sequence=Displayed;
CC       Name=2; Synonyms=TPO2;
CC         IsoId=P07202-2; Sequence=VSP_004665;
CC       Name=3; Synonyms=TPO3, Graves' disease, TPOzaninelli;
CC         IsoId=P07202-3; Sequence=VSP_004666;
CC       Name=4; Synonyms=TPO4;
CC         IsoId=P07202-4; Sequence=VSP_007269;
CC       Name=5; Synonyms=TPO5;
CC         IsoId=P07202-5; Sequence=VSP_007268;
CC       Name=6; Synonyms=TPO6;
CC         IsoId=P07202-6; Sequence=VSP_004665, VSP_007270;
CC       Name=2-3;
CC         IsoId=P07202-7; Sequence=VSP_004665, VSP_004666;
CC       Name=2-4;
CC         IsoId=P07202-8; Sequence=VSP_004665, VSP_007269;
CC   -!- PTM: Glycosylated.
CC   -!- PTM: Heme is covalently bound through a H(2)O(2)-dependent
CC       autocatalytic process. Heme insertion is important for the delivery of
CC       protein at the cell surface.
CC   -!- PTM: Cleaved in its N-terminal part.
CC   -!- DISEASE: Note=An alternative splicing in the thyroperoxidase mRNA can
CC       cause Graves' disease.
CC   -!- DISEASE: Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]: A disorder
CC       due to defective conversion of accumulated iodide to organically bound
CC       iodine. The iodide organification defect can be partial or complete.
CC       {ECO:0000269|PubMed:10084596, ECO:0000269|PubMed:10468986,
CC       ECO:0000269|PubMed:11061528, ECO:0000269|PubMed:11415848,
CC       ECO:0000269|PubMed:11874711, ECO:0000269|PubMed:11916616,
CC       ECO:0000269|PubMed:12213873, ECO:0000269|PubMed:12490071,
CC       ECO:0000269|PubMed:12843174, ECO:0000269|PubMed:12864797,
CC       ECO:0000269|PubMed:12938097, ECO:0000269|PubMed:16284446,
CC       ECO:0000269|PubMed:16684826, ECO:0000269|PubMed:27305979,
CC       ECO:0000269|PubMed:7550241, ECO:0000269|PubMed:9024270,
CC       ECO:0000269|PubMed:9924196}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 2]: Lacks exon 10. Found in normal thyroid
CC       tissues as well as Graves'tissues. Rapidly degraded after synthesis,
CC       does not reach the cell surface. Inactive. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Lacks exon 16. Found in normal thyroid
CC       tissues as well as Graves'tissues. Active. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Lacks exon 14. Active. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 5]: Lacks exon 8. Does not fold correctly. Does
CC       not reach the cell surface. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 6]: Lacks exons 10, 12, 13, 14 and 16.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 2-3]: Lacks exons 10 and 16. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 2-4]: Lacks exons 10 and 14. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the peroxidase family. XPO subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00298}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Thyroid peroxidase entry;
CC       URL="https://en.wikipedia.org/wiki/Thyroid_peroxidase";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02969; AAA61215.1; -; mRNA.
DR   EMBL; J02970; AAA61216.1; -; mRNA.
DR   EMBL; Y00406; CAA68467.1; -; mRNA.
DR   EMBL; M25715; AAA97517.1; -; Genomic_DNA.
DR   EMBL; M25702; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25703; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25704; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25705; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25706; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25707; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25708; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25709; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25710; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25711; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25712; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25713; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; M25714; AAA97517.1; JOINED; Genomic_DNA.
DR   EMBL; X17358; CAA35235.1; -; mRNA.
DR   EMBL; M17755; AAA61217.2; -; mRNA.
DR   EMBL; AF439430; AAL74416.1; -; mRNA.
DR   EMBL; AF533528; AAN04471.1; -; mRNA.
DR   EMBL; AY136822; AAN11302.1; -; mRNA.
DR   EMBL; AF533529; AAN04472.1; -; mRNA.
DR   EMBL; AF533530; AAN04473.1; -; mRNA.
DR   EMBL; AF533531; AAN04474.1; -; mRNA.
DR   EMBL; M55702; AAA61219.1; -; mRNA.
DR   EMBL; M55702; AAA61218.1; -; mRNA.
DR   CCDS; CCDS1643.1; -. [P07202-1]
DR   CCDS; CCDS1644.1; -. [P07202-2]
DR   CCDS; CCDS1646.1; -. [P07202-5]
DR   PIR; A32413; OPHUIT.
DR   RefSeq; NP_000538.3; NM_000547.5. [P07202-1]
DR   RefSeq; NP_001193673.1; NM_001206744.1. [P07202-1]
DR   RefSeq; NP_001193674.1; NM_001206745.1. [P07202-2]
DR   RefSeq; NP_783650.1; NM_175719.3. [P07202-2]
DR   RefSeq; NP_783652.1; NM_175721.3. [P07202-4]
DR   RefSeq; NP_783653.1; NM_175722.3. [P07202-5]
DR   RefSeq; XP_011508683.1; XM_011510381.2.
DR   AlphaFoldDB; P07202; -.
DR   SMR; P07202; -.
DR   BioGRID; 113026; 6.
DR   STRING; 9606.ENSP00000318820; -.
DR   BindingDB; P07202; -.
DR   ChEMBL; CHEMBL1839; -.
DR   DrugBank; DB11496; 2-mercaptobenzothiazole.
DR   DrugBank; DB00389; Carbimazole.
DR   DrugBank; DB00509; Dextrothyroxine.
DR   DrugBank; DB05382; Iodine.
DR   DrugBank; DB00763; Methimazole.
DR   DrugBank; DB00550; Propylthiouracil.
DR   DrugBank; DB11085; Resorcinol.
DR   DrugBank; DB08604; Triclosan.
DR   DrugCentral; P07202; -.
DR   GuidetoPHARMACOLOGY; 2526; -.
DR   Allergome; 9554; Hom s TPO.
DR   PeroxiBase; 3318; HsTPO01.
DR   GlyCosmos; P07202; 4 sites, No reported glycans.
DR   GlyGen; P07202; 5 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; P07202; -.
DR   PhosphoSitePlus; P07202; -.
DR   BioMuta; TPO; -.
DR   DMDM; 160281455; -.
DR   MassIVE; P07202; -.
DR   PaxDb; P07202; -.
DR   PeptideAtlas; P07202; -.
DR   ProteomicsDB; 51964; -. [P07202-1]
DR   ProteomicsDB; 51965; -. [P07202-2]
DR   ProteomicsDB; 51966; -. [P07202-3]
DR   ProteomicsDB; 51967; -. [P07202-4]
DR   ProteomicsDB; 51968; -. [P07202-5]
DR   ProteomicsDB; 51969; -. [P07202-6]
DR   ProteomicsDB; 51970; -. [P07202-7]
DR   ProteomicsDB; 51971; -. [P07202-8]
DR   ABCD; P07202; 56 sequenced antibodies.
DR   Antibodypedia; 2364; 697 antibodies from 35 providers.
DR   DNASU; 7173; -.
DR   Ensembl; ENST00000329066.9; ENSP00000329869.4; ENSG00000115705.22. [P07202-1]
DR   Ensembl; ENST00000345913.8; ENSP00000318820.7; ENSG00000115705.22. [P07202-1]
DR   Ensembl; ENST00000346956.7; ENSP00000263886.6; ENSG00000115705.22. [P07202-4]
DR   Ensembl; ENST00000382198.5; ENSP00000371633.1; ENSG00000115705.22. [P07202-5]
DR   Ensembl; ENST00000382201.7; ENSP00000371636.3; ENSG00000115705.22. [P07202-2]
DR   GeneID; 7173; -.
DR   KEGG; hsa:7173; -.
DR   MANE-Select; ENST00000329066.9; ENSP00000329869.4; NM_001206744.2; NP_001193673.1.
DR   UCSC; uc002qwr.4; human. [P07202-1]
DR   AGR; HGNC:12015; -.
DR   CTD; 7173; -.
DR   DisGeNET; 7173; -.
DR   GeneCards; TPO; -.
DR   HGNC; HGNC:12015; TPO.
DR   HPA; ENSG00000115705; Tissue enriched (thyroid).
DR   MalaCards; TPO; -.
DR   MIM; 274500; phenotype.
DR   MIM; 606765; gene.
DR   neXtProt; NX_P07202; -.
DR   OpenTargets; ENSG00000115705; -.
DR   Orphanet; 95716; Familial thyroid dyshormonogenesis.
DR   PharmGKB; PA36694; -.
DR   VEuPathDB; HostDB:ENSG00000115705; -.
DR   eggNOG; KOG2408; Eukaryota.
DR   GeneTree; ENSGT00940000158104; -.
DR   InParanoid; P07202; -.
DR   OMA; HPCFPIE; -.
DR   OrthoDB; 4560at2759; -.
DR   PhylomeDB; P07202; -.
DR   TreeFam; TF314316; -.
DR   BRENDA; 1.11.1.8; 2681.
DR   BRENDA; 3.6.1.52; 2681.
DR   PathwayCommons; P07202; -.
DR   Reactome; R-HSA-209968; Thyroxine biosynthesis.
DR   SignaLink; P07202; -.
DR   SIGNOR; P07202; -.
DR   UniPathway; UPA00194; -.
DR   BioGRID-ORCS; 7173; 8 hits in 1150 CRISPR screens.
DR   ChiTaRS; TPO; human.
DR   GenomeRNAi; 7173; -.
DR   Pharos; P07202; Tclin.
DR   PRO; PR:P07202; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P07202; protein.
DR   Bgee; ENSG00000115705; Expressed in left lobe of thyroid gland and 92 other tissues.
DR   ExpressionAtlas; P07202; baseline and differential.
DR   Genevisible; P07202; HS.
DR   GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0004447; F:iodide peroxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004601; F:peroxidase activity; IBA:GO_Central.
DR   GO; GO:0035162; P:embryonic hemopoiesis; IDA:DFLAT.
DR   GO; GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:InterPro.
DR   GO; GO:0006590; P:thyroid hormone generation; TAS:Reactome.
DR   CDD; cd00033; CCP; 1.
DR   CDD; cd00054; EGF_CA; 1.
DR   CDD; cd09825; thyroid_peroxidase; 1.
DR   Gene3D; 2.10.70.10; Complement Module, domain 1; 1.
DR   Gene3D; 1.10.640.10; Haem peroxidase domain superfamily, animal type; 1.
DR   Gene3D; 2.10.25.10; Laminin; 1.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR019791; Haem_peroxidase_animal.
DR   InterPro; IPR010255; Haem_peroxidase_sf.
DR   InterPro; IPR037120; Haem_peroxidase_sf_animal.
DR   InterPro; IPR035976; Sushi/SCR/CCP_sf.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   InterPro; IPR029589; TPO.
DR   PANTHER; PTHR11475; OXIDASE/PEROXIDASE; 1.
DR   PANTHER; PTHR11475:SF60; THYROID PEROXIDASE; 1.
DR   Pfam; PF03098; An_peroxidase; 1.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF00084; Sushi; 1.
DR   PRINTS; PR00457; ANPEROXIDASE.
DR   SMART; SM00032; CCP; 1.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00179; EGF_CA; 1.
DR   SUPFAM; SSF57535; Complement control module/SCR domain; 1.
DR   SUPFAM; SSF57196; EGF/Laminin; 1.
DR   SUPFAM; SSF48113; Heme-dependent peroxidases; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS01187; EGF_CA; 1.
DR   PROSITE; PS00435; PEROXIDASE_1; 1.
DR   PROSITE; PS50292; PEROXIDASE_3; 1.
DR   PROSITE; PS50923; SUSHI; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Congenital hypothyroidism; Disease variant;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Heme; Hydrogen peroxide;
KW   Iron; Membrane; Metal-binding; Oxidoreductase; Peroxidase;
KW   Reference proteome; Signal; Sushi; Thyroid hormones biosynthesis;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..933
FT                   /note="Thyroid peroxidase"
FT                   /id="PRO_0000023662"
FT   TOPO_DOM        19..846
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        847..871
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        872..933
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          740..795
FT                   /note="Sushi"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          796..839
FT                   /note="EGF-like; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          881..933
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        918..933
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        239
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   BINDING         238
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /note="covalent"
FT                   /evidence="ECO:0000250"
FT   BINDING         240
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   BINDING         321
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   BINDING         323
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   BINDING         325
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   BINDING         327
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   BINDING         399
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /note="covalent"
FT                   /evidence="ECO:0000250"
FT   BINDING         494
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   SITE            396
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00298"
FT   CARBOHYD        129
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        307
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        342
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        569
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        142..158
FT                   /evidence="ECO:0000250"
FT   DISULFID        259..269
FT                   /evidence="ECO:0000250"
FT   DISULFID        263..286
FT                   /evidence="ECO:0000250"
FT   DISULFID        598..655
FT                   /evidence="ECO:0000250"
FT   DISULFID        696..721
FT                   /evidence="ECO:0000250"
FT   DISULFID        800..814
FT                   /evidence="ECO:0000250"
FT   DISULFID        808..823
FT                   /evidence="ECO:0000250"
FT   DISULFID        825..838
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         274..446
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|Ref.6"
FT                   /id="VSP_007268"
FT   VAR_SEQ         534..590
FT                   /note="Missing (in isoform 2, isoform 2-3, isoform 2-4 and
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:2308857,
FT                   ECO:0000303|PubMed:3475693"
FT                   /id="VSP_004665"
FT   VAR_SEQ         669..933
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_007270"
FT   VAR_SEQ         796..839
FT                   /note="Missing (in isoform 4 and isoform 2-4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_007269"
FT   VAR_SEQ         874..933
FT                   /note="TRTGTKSTLPISETGGGTPELRCGKHQAVGTSPQRAAAQDSEQESAGMEGRD
FT                   THRLPRAL -> RVLGWKAGILTGCREPSEGKVAGHCRTASCSQNHRTTLFQTQANRKS
FT                   AGRLFSQHG (in isoform 3 and isoform 2-3)"
FT                   /evidence="ECO:0000303|PubMed:2383265"
FT                   /id="VSP_004666"
FT   VARIANT         53
FT                   /note="A -> P (in TDH2A)"
FT                   /evidence="ECO:0000269|PubMed:12213873"
FT                   /id="VAR_021622"
FT   VARIANT         240
FT                   /note="D -> N (in TDH2A; loss of activity;
FT                   dbSNP:rs1427024341)"
FT                   /evidence="ECO:0000269|PubMed:9924196"
FT                   /id="VAR_021623"
FT   VARIANT         257
FT                   /note="A -> S (in dbSNP:rs4927611)"
FT                   /evidence="ECO:0000269|PubMed:7550241, ECO:0000269|Ref.5,
FT                   ECO:0000269|Ref.6"
FT                   /id="VAR_006057"
FT   VARIANT         307
FT                   /note="N -> T (in TDH2A)"
FT                   /evidence="ECO:0000269|PubMed:12938097"
FT                   /id="VAR_021624"
FT   VARIANT         326
FT                   /note="A -> T (in TDH2A; dbSNP:rs371367459)"
FT                   /evidence="ECO:0000269|PubMed:11061528"
FT                   /id="VAR_021625"
FT   VARIANT         373
FT                   /note="A -> S (in dbSNP:rs2280132)"
FT                   /evidence="ECO:0000269|PubMed:7550241"
FT                   /id="VAR_006058"
FT   VARIANT         378
FT                   /note="E -> K (in TDH2A; dbSNP:rs1297312788)"
FT                   /evidence="ECO:0000269|PubMed:16284446"
FT                   /id="VAR_025784"
FT   VARIANT         398
FT                   /note="S -> T (in dbSNP:rs2175977)"
FT                   /evidence="ECO:0000269|PubMed:7550241"
FT                   /id="VAR_006059"
FT   VARIANT         412
FT                   /note="R -> H (in TDH2A; unknown pathological significance;
FT                   dbSNP:rs1173922703)"
FT                   /evidence="ECO:0000269|PubMed:27305979"
FT                   /id="VAR_078336"
FT   VARIANT         433
FT                   /note="V -> M (in TDH2A; dbSNP:rs1035791118)"
FT                   /evidence="ECO:0000269|PubMed:12938097"
FT                   /id="VAR_021626"
FT   VARIANT         447
FT                   /note="I -> F (in TDH2A; dbSNP:rs104893669)"
FT                   /evidence="ECO:0000269|PubMed:11061528,
FT                   ECO:0000269|PubMed:9024270"
FT                   /id="VAR_015375"
FT   VARIANT         453
FT                   /note="Y -> D (in TDH2A; dbSNP:rs121908083)"
FT                   /evidence="ECO:0000269|PubMed:11061528,
FT                   ECO:0000269|PubMed:16684826, ECO:0000269|PubMed:7550241"
FT                   /id="VAR_006060"
FT   VARIANT         458
FT                   /note="L -> P (in TDH2A; dbSNP:rs1231870370)"
FT                   /evidence="ECO:0000269|PubMed:11415848"
FT                   /id="VAR_021627"
FT   VARIANT         491
FT                   /note="R -> H (in TDH2A; dbSNP:rs201165648)"
FT                   /evidence="ECO:0000269|PubMed:11415848"
FT                   /id="VAR_021628"
FT   VARIANT         493
FT                   /note="G -> S (in TDH2A; dbSNP:rs778515113)"
FT                   /evidence="ECO:0000269|PubMed:11874711"
FT                   /id="VAR_021629"
FT   VARIANT         499
FT                   /note="P -> L (in TDH2A; dbSNP:rs1169072188)"
FT                   /evidence="ECO:0000269|PubMed:12938097"
FT                   /id="VAR_021630"
FT   VARIANT         527
FT                   /note="W -> C (in TDH2A; dbSNP:rs779434941)"
FT                   /evidence="ECO:0000269|PubMed:11061528"
FT                   /id="VAR_021631"
FT   VARIANT         533
FT                   /note="G -> C (in TDH2A; partial defect; expression
FT                   slightly lower in efficiency and more degenerative than
FT                   wild-type enzyme)"
FT                   /evidence="ECO:0000269|PubMed:12864797"
FT                   /id="VAR_027229"
FT   VARIANT         574..575
FT                   /note="Missing (in TDH2A; partial defect; expressed on the
FT                   plasma membrane surface at less than half the rate of
FT                   wild-type enzyme)"
FT                   /id="VAR_027230"
FT   VARIANT         590
FT                   /note="G -> S (in TDH2A; dbSNP:rs121908084)"
FT                   /evidence="ECO:0000269|PubMed:7550241"
FT                   /id="VAR_027231"
FT   VARIANT         596..933
FT                   /note="Missing (in TDH2A; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:27305979"
FT                   /id="VAR_078337"
FT   VARIANT         618
FT                   /note="V -> M (in dbSNP:rs10189135)"
FT                   /id="VAR_027232"
FT   VARIANT         648
FT                   /note="R -> Q (in TDH2A; dbSNP:rs121908086)"
FT                   /evidence="ECO:0000269|PubMed:10084596"
FT                   /id="VAR_013138"
FT   VARIANT         660
FT                   /note="Q -> E (in TDH2A; dbSNP:rs121908088)"
FT                   /evidence="ECO:0000269|PubMed:10468986"
FT                   /id="VAR_021632"
FT   VARIANT         665
FT                   /note="R -> W (in TDH2A; fails to localize to the plasma
FT                   membrane; dbSNP:rs776742629)"
FT                   /evidence="ECO:0000269|PubMed:11916616"
FT                   /id="VAR_021633"
FT   VARIANT         693
FT                   /note="R -> W (in TDH2A; dbSNP:rs121908087)"
FT                   /evidence="ECO:0000269|PubMed:11061528,
FT                   ECO:0000269|PubMed:12843174"
FT                   /id="VAR_021634"
FT   VARIANT         706
FT                   /note="M -> V (in dbSNP:rs13431173)"
FT                   /id="VAR_027233"
FT   VARIANT         725
FT                   /note="T -> P (in dbSNP:rs732609)"
FT                   /evidence="ECO:0000269|PubMed:12454013,
FT                   ECO:0000269|PubMed:3453124, ECO:0000269|PubMed:3475693,
FT                   ECO:0000269|PubMed:7550241, ECO:0000269|Ref.6"
FT                   /id="VAR_006061"
FT   VARIANT         771
FT                   /note="G -> R (in TDH2A; fails to localize to the plasma
FT                   membrane; dbSNP:rs138931129)"
FT                   /evidence="ECO:0000269|PubMed:11916616"
FT                   /id="VAR_021635"
FT   VARIANT         793
FT                   /note="L -> P (in dbSNP:rs28991293)"
FT                   /id="VAR_027234"
FT   VARIANT         796
FT                   /note="D -> Y (in TDH2A)"
FT                   /evidence="ECO:0000269|PubMed:11874711"
FT                   /id="VAR_021636"
FT   VARIANT         799
FT                   /note="E -> K (in TDH2A; dbSNP:rs121908085)"
FT                   /evidence="ECO:0000269|PubMed:10084596,
FT                   ECO:0000269|PubMed:11061528, ECO:0000269|PubMed:7550241"
FT                   /id="VAR_006062"
FT   VARIANT         808
FT                   /note="C -> R (in TDH2A; dbSNP:rs935058009)"
FT                   /evidence="ECO:0000269|PubMed:12938097"
FT                   /id="VAR_021637"
FT   VARIANT         839
FT                   /note="V -> I (in TDH2A; dbSNP:rs146351101)"
FT                   /evidence="ECO:0000269|PubMed:12490071"
FT                   /id="VAR_027235"
FT   VARIANT         846
FT                   /note="R -> W (in dbSNP:rs28913014)"
FT                   /id="VAR_027236"
FT   VARIANT         847
FT                   /note="V -> A (in dbSNP:rs1126799)"
FT                   /evidence="ECO:0000269|PubMed:12454013,
FT                   ECO:0000269|PubMed:3453124, ECO:0000269|PubMed:3475693,
FT                   ECO:0000269|Ref.6"
FT                   /id="VAR_027237"
FT   CONFLICT        70
FT                   /note="P -> G (in Ref. 5; AAA61217)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        354
FT                   /note="A -> G (in Ref. 5 and 8)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        371
FT                   /note="A -> R (in Ref. 1; AAA61215/AAA61216)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        381
FT                   /note="I -> N (in Ref. 5 and 8)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        574
FT                   /note="D -> N (in Ref. 2; CAA68467)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        732
FT                   /note="W -> C (in Ref. 7; AAN11302)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        748
FT                   /note="V -> M (in Ref. 2 and 7)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        816
FT                   /note="N -> S (in Ref. 6; AAL74416)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        872
FT                   /note="R -> K (in Ref. 2 and 7)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   933 AA;  102963 MW;  F67C5F1A4AEE0B29 CRC64;
     MRALAVLSVT LVMACTEAFF PFISRGKELL WGKPEESRVS SVLEESKRLV DTAMYATMQR
     NLKKRGILSP AQLLSFSKLP EPTSGVIARA AEIMETSIQA MKRKVNLKTQ QSQHPTDALS
     EDLLSIIANM SGCLPYMLPP KCPNTCLANK YRPITGACNN RDHPRWGASN TALARWLPPV
     YEDGFSQPRG WNPGFLYNGF PLPPVREVTR HVIQVSNEVV TDDDRYSDLL MAWGQYIDHD
     IAFTPQSTSK AAFGGGADCQ MTCENQNPCF PIQLPEEARP AAGTACLPFY RSSAACGTGD
     QGALFGNLST ANPRQQMNGL TSFLDASTVY GSSPALERQL RNWTSAEGLL RVHARLRDSG
     RAYLPFVPPR APAACAPEPG IPGETRGPCF LAGDGRASEV PSLTALHTLW LREHNRLAAA
     LKALNAHWSA DAVYQEARKV VGALHQIITL RDYIPRILGP EAFQQYVGPY EGYDSTANPT
     VSNVFSTAAF RFGHATIHPL VRRLDASFQE HPDLPGLWLH QAFFSPWTLL RGGGLDPLIR
     GLLARPAKLQ VQDQLMNEEL TERLFVLSNS STLDLASINL QRGRDHGLPG YNEWREFCGL
     PRLETPADLS TAIASRSVAD KILDLYKHPD NIDVWLGGLA ENFLPRARTG PLFACLIGKQ
     MKALRDGDWF WWENSHVFTD AQRRELEKHS LSRVICDNTG LTRVPMDAFQ VGKFPEDFES
     CDSITGMNLE AWRETFPQDD KCGFPESVEN GDFVHCEESG RRVLVYSCRH GYELQGREQL
     TCTQEGWDFQ PPLCKDVNEC ADGAHPPCHA SARCRNTKGG FQCLCADPYE LGDDGRTCVD
     SGRLPRVTWI SMSLAALLIG GFAGLTSTVI CRWTRTGTKS TLPISETGGG TPELRCGKHQ
     AVGTSPQRAA AQDSEQESAG MEGRDTHRLP RAL
//
